Insiders Trades
Takeda Pharmaceutical Company Limited Stock: price and insider trades · Japan
武田薬品工業株式会社
JP·Mcap JP¥9.4T
Takeda Pharmaceutical Company Limited: what insiders have been doing
We have very little insider data for Takeda Pharmaceutical Company Limited so far: the most recent filing dates from 17 September 2026. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Takeda Pharmaceutical Company Limited Buy (bullish), based on 16 analysts. Average price target: JP¥6,622.
Fundamental score
Ranked 17,316 of 24,148 companies
37.1
score / 100
Value40
Quality35
FCF yld6.3%
Earn yld-1.5%
EV/EBITDA20.4x
ROE-2.3%
Gross mgn65%
Net mgn-3.4%
Debt/EBITDA6.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥5,889
Analyst consensus
16 analystsBuy
JP¥5,800Target JP¥6,622(+12%)JP¥7,600
Income statement
RevenueJP¥4.5T
Gross profitJP¥2.9T65% margin
EBITDAJP¥726.9B16% margin
Net income-JP¥152.4B-3.5% margin
Valuation
P/Book1.2x
Beta0.10
Balance sheet & cash
Market capJP¥9.4T
Total debtJP¥4.9T
Free Cash FlowJP¥626.8B
Debt / Equity73%
Profitability & ownership
ROE-2.3%
ROA2.7%
% insiders0.1%
% institutions50.2%
Last declaration on 17 September 2026
Declarations5 total
ShareXTKSEDINET:S100Z2WE
ShareXTKSEDINET:S100WPC9
ShareXTKSEDINET:S100VMSK
ShareXTKSEDINET:S100TAGD
ShareXTKSEDINET:S100S19Z
5 of 5 declarations
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a Japanese pharmaceutical company focused on the research, development, and marketing of medications. It is listed on the Tokyo Stock Exchange under the symbol XTKS.